[HTML][HTML] Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic …
HJ Lee, HJ Jang, WI Choi, J Joh, J Kim… - … and Critical care, 2023 - synapse.koreamed.org
Background Patients with coronavirus disease 2019 (COVID-19) infections often have
macrovascular or microvascular thrombosis and inflammation, which are known to be …
macrovascular or microvascular thrombosis and inflammation, which are known to be …
[HTML][HTML] Thrombotic risk in patients with COVID-19
E Pancaldi, G Pascariello, G Cimino… - Reviews in …, 2021 - imrpress.com
Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-
19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical …
19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical …
A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population
KC Poh, VYJ Tay, SH Lin, HL Chee… - Singapore Medical …, 2022 - journals.lww.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has placed an immense
burden on healthcare systems worldwide. There is intensive research targeted at better …
burden on healthcare systems worldwide. There is intensive research targeted at better …
Thrombosis risk associated with COVID-19 infection. A scoping review
F Al-Ani, S Chehade, A Lazo-Langner - Thrombosis research, 2020 - Elsevier
Background Infection by the 2019 novel coronavirus (COVID-19) has been reportedly
associated with a high risk of thrombotic complications. So far information is scarce and …
associated with a high risk of thrombotic complications. So far information is scarce and …
[HTML][HTML] Bleeding risk by intensity of anticoagulation in critically ill patients with COVID‐19: a retrospective cohort study
Background Studies report hypercoagulability in coronavirus disease 2019 (COVID‐19),
leading many institutions to escalate anticoagulation intensity for thrombosis prophylaxis …
leading many institutions to escalate anticoagulation intensity for thrombosis prophylaxis …
Thrombotic and hypercoagulability complications of COVID-19: an update
S Shibeeb, MN Ahmad - Journal of Blood Medicine, 2021 - Taylor & Francis
The current COVID-19 pandemic emerged in December 2019, in China, affecting millions of
people worldwide. COVID-19 is mainly a disease of the respiratory system, yet systematic …
people worldwide. COVID-19 is mainly a disease of the respiratory system, yet systematic …
COVID-19-associated coagulopathy and immuno-thrombosis
D Celovska, M Wawruch, V Stvrtinova - Acta Phlebologica, 2021 - minervamedica.it
The global pandemic Coronavirus disease 2019 (COVID-19) is caused by a novel highly
virulent beta-coronavirus SARS-CoV-2. The infection SARS-CoV-2 is associated with a …
virulent beta-coronavirus SARS-CoV-2. The infection SARS-CoV-2 is associated with a …
Anticoagulation in COVID-19: a systematic review, meta-analysis, and rapid guidance from Mayo Clinic
RD McBane II, VDT Roldan, AS Niven, RK Pruthi… - Mayo Clinic …, 2020 - Elsevier
A higher risk of thrombosis has been described as a prominent feature of coronavirus
disease 2019 (COVID-19). This systematic review synthesizes current data on thrombosis …
disease 2019 (COVID-19). This systematic review synthesizes current data on thrombosis …
Coronavirus-induced coagulopathy during the course of disease
MS Friedrich, JD Studt, J Braun, DR Spahn… - PLoS One, 2020 - journals.plos.org
Background A significant proportion of patients with coronavirus disease 19 (COVID-19)
suffer from excessive coagulation activation and coagulopathy which is associated with an …
suffer from excessive coagulation activation and coagulopathy which is associated with an …
Management of thrombotic complications in COVID-19: an update
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV‑2), is now a global pandemic. This virus primarily …
syndrome coronavirus 2 (SARS-CoV‑2), is now a global pandemic. This virus primarily …